Nanobiosensors for early detection of neurodegenerative disease

Authors

  • Paria Fazlali Department of Biomedical Engineering, Tehran University of Medical Sience, Tehran, Iran.
  • Aida Mahdian Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • Mohammad Sina Soheilifar Department of Biomedical Engineering, University of Science and Arts, Yazd, Iran
  • Seyed Mojtaba Amininasab Department of Chemistry, University of Kurdistan, Sanandaj, Iran
  • Parisa Shafiee School of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Tehran, Iran
  • Irshad Ahmad Wani Department of Chemistry, University of Jammu, Jammu & Kashmir, India, 182222
  • Ali M.A. Abdul Amir AL-Mokaram Department of Chemistry, Mustansiriyah University, 10052 Baghdad, Iraq

DOI:

https://doi.org/10.52547/jcc.4.1.4

Keywords:

Early diagnosis, Neurodegenerative disease, Nanobiosensors, Optical biosensors, Electrochemical biosensors

Abstract

Early detection of neurodegeneration-related disorders that emerge as people age, is critical for both the disease's treatment and the patient's living conditions. Parkinson's and Alzheimer's illnesses are two well-known instances of neurodegeneration, which are characterized by nerve cell death and dementia. The fact is that some illnesses are only diagnosed clinically after symptoms develop hinders therapy. The biomarkers detection, which are unique chemicals found in bodily fluids and are implicated in neurodegenerative processes, may assist in the early detection of neurodegenerative illnesses. Recent years have seen a surge in interest in biosensor research, with the goal of detecting possible biomarkers of the neurodegenerative process with appropriate precision. Biosensors' main purpose is to identify a specific material with high specificity. This manuscript reviews neuro-biosensors for the prognosis of neurodegenerative illnesses like Parkinson's disease (PD) and Alzheimer's disease (AD), as well as a summary of the field's urgent needs, highlighting the critical importance of early detection along the neurodegeneration pathway in general. This study examines biosensor systems designed to identify biomarkers of neurodegenerative diseases (NDDs), with an emphasis on the last five years.

Graphical Abstract

Downloads

Published

2022-03-31

How to Cite

Fazlali, P., Mahdian, A., Soheilifar, M. S., Amininasab, S. M., Shafiee, P., Wani, I. A., & AL-Mokaram, A. M. A. A. (2022). Nanobiosensors for early detection of neurodegenerative disease. Journal of Composites and Compounds, 4(10), 24–36. https://doi.org/10.52547/jcc.4.1.4

Issue

Vol. 4 No. 10 (2022)

Section

Review Articles

Categories

License

Copyright (c) 2022 JCC Research Group

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors will be asked, upon acceptance of an article, to transfer copyright of the article to the Publisher. This will ensure the widest possible dissemination of information under copyright laws. The submitted materials may be considered for inclusion but can not be returned.

Licensing: The JCC articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source (appropriate citation), provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

*Author rights
As an author you (or your employer or institution) have certain rights to reuse your work.